Exercise Training to Increase Tumour Natural Killer-cell Infiltration in Men with Localised Prostate Cancer: a Randomised Controlled Trial
Authors
Affiliations
Objectives: To explore the effects of preoperative high-intensity interval training (HIIT) compared to usual care on tumour natural killer (NK)-cell infiltration in men with localised prostate cancer (PCa), as NK-cell infiltration has been proposed as one of the key mechanisms whereby exercise can modulate human tumours.
Patients And Methods: A total of 30 patients with localised PCa undergoing radical prostatectomy (RP) were randomised (2:1) to either preoperative aerobic HIIT four-times weekly (EX; n = 20) or usual care (CON; n = 10) from time of inclusion until scheduled surgery. Tumour NK-cell infiltration was assessed by immunohistochemistry (CD56 ) in diagnostic core needle biopsies and corresponding prostatic tissue from the RP. Changes in cardiorespiratory fitness, body composition, blood biochemistry, and health-related quality of life were also evaluated.
Results: The change in tumour NK-cell infiltration did not differ between the EX and CON groups (between-group difference: -0.09 cells/mm , 95% confidence interval [CI] -1.85 to 1.66; P = 0.913) in the intention-to-treat analysis. The total number of exercise sessions varied considerably from four to 30 sessions. The per-protocol analysis showed a significant increase in tumour NK-cell infiltration of 1.60 cells/mm (95% CI 0.59 to 2.62; P = 0.004) in the EX group. Further, the total number of training sessions was positively correlated with the change in NK-cell infiltration (r = 0.526, P = 0.021), peak oxygen uptake (r = 0.514, P = 0.035) and peak power output (r = 0.506, P = 0.038).
Conclusion: Preoperative HIIT did not result in between-group differences in tumour NK-cell infiltration. Per-protocol and exploratory analyses demonstrate an enhanced NK-cell infiltration in PCa. Future studies are needed to test the capability of exercise to increase tumour immune cell infiltration.
Dias-da-Silva Jr G, Panissa V, Derchain S, Ferreira M, Telles G, Buzaglo G Sports Med. 2024; .
PMID: 39602033 DOI: 10.1007/s40279-024-02145-7.
Emerging Mechanisms of Physical Exercise Benefits in Adjuvant and Neoadjuvant Cancer Immunotherapy.
Casciano F, Caruso L, Zauli E, Gonelli A, Zauli G, Vaccarezza M Biomedicines. 2024; 12(11).
PMID: 39595094 PMC: 11591576. DOI: 10.3390/biomedicines12112528.
Exercise and tumor proteome: insights from a neuroblastoma model.
Plaza-Florido A, Galvez B, Lopez J, Santos-Lozano A, Zazo S, Rincon-Castanedo C Physiol Genomics. 2024; 56(12):833-844.
PMID: 39311839 PMC: 11573273. DOI: 10.1152/physiolgenomics.00064.2024.
Llorente A, Brokane A, Mlynska A, Puurand M, Sagini K, Folkmane S J Extracell Vesicles. 2024; 13(8):e12500.
PMID: 39183543 PMC: 11345496. DOI: 10.1002/jev2.12500.
Parent-Roberge H, Fontvieille A, Poirier L, Tai L, Pavic M, Fulop T Brain Behav Immun Health. 2024; 40:100825.
PMID: 39155952 PMC: 11327397. DOI: 10.1016/j.bbih.2024.100825.